sur LR Health & Beauty SE (isin : NO0013149658)
LR Health & Beauty SE Adjusts 2024 Financial Forecasts Amid Sales Growth
On November 26, 2024, LR Health & Beauty SE disclosed its Q3 2024 figures, noting a significant increase in sales and an adjustment of its financial forecasts for the year. In Q3 2024, sales increased by 7.2% to EUR 69.4 million, compared to EUR 64.7 million in Q3 2023. Cumulatively, sales for the first nine months of 2024 totaled EUR 212.7 million, up from EUR 205.6 million in 2023.
Despite a slight year-on-year decline in EBITDA, which was EUR 19.0 million for the first nine months of 2024 versus EUR 22.4 million in 2023, the company adjusted its forecast. The new sales forecast for 2024 ranges between EUR 288 million and EUR 292 million, higher than the previous year's EUR 276.5 million. EBITDA is expected to range between EUR 26 million and EUR 29 million, adjusted due to distributor realignment costs and refinancing.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de LR Health & Beauty SE